Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies

Intern Med J. 2019 Oct;49(10):1338. doi: 10.1111/imj.14453.

Authors

Michael Dickinson^{1

2}, Robert Weinkove^{3

4}

Affiliations

¹ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
³ Malaghan Institute, Wellington, New Zealand.
⁴ Wellington Blood and Cancer Centre, Wellington, New Zealand.

PMID: 31602776
DOI: 10.1111/imj.14453

No abstract available

Publication types

Letter
Comment

MeSH terms

Australia
Humans
Lymphoma, Follicular*
Lymphoma, Non-Hodgkin*
Receptors, Chimeric Antigen
T-Lymphocytes

Substances

Receptors, Chimeric Antigen